Shanghai Nianxing Industrial Co., Ltd
China
Product Name: Palmitic acid
Price: Check
Purity: 98.0%
Stocking Period: 10 Day
Contact: Yang
Email: sales@echemcloud.com

1654776-91-6

1654776-91-6 structure

1654776-91-6 structure

Name: JAK-IN-20
Chemical Name: JAK-IN-20
CAS Number: 1654776-91-6
Molecular Formula: C₂₈H₃₀FN₇O₂
Molecular Weight: 515.58
Catalog: Signaling Pathways Epigenetics JAK
Create Date: 2022-07-01 15:05:45
Modify Date: 2025-08-28 16:15:02
JAK-IN-20 is a potent, pan and orally active JAK inhibitor with an IC50s of 7 nM, 5 nM, 14 nM for JAK1, JAK2, JAK3, respectively. JAK-IN-20 shows excellent pharmacokinetics and displays anti-inflammatory efficacy in vivo[1].

Name	JAK-IN-20

Description	JAK-IN-20 is a potent, pan and orally active JAK inhibitor with an IC50s of 7 nM, 5 nM, 14 nM for JAK1, JAK2, JAK3, respectively. JAK-IN-20 shows excellent pharmacokinetics and displays anti-inflammatory efficacy in vivo[1].
Related Catalog	Signaling Pathways >> JAK/STAT Signaling >> JAK Signaling Pathways >> Epigenetics >> JAK Signaling Pathways >> Stem Cell/Wnt >> JAK Research Areas >> Inflammation/Immunology
Target	JAK1:7 nM (IC50) JAK2:5 nM (IC50) JAK3:14 nM (IC50)
In Vivo	JAK-IN-20 (compound 32) (3 mg/kg for p.o.; 1 mg/kg for i.v.) shows excellent pharmacokinetics in rats[1]. JAK-IN-20 (10 mg/kg; p.o.; once a day for 3 days) shows anti-inflammatory effect[1]. Pharmacokinetic Parameters of JAK-IN-20 in female Sprague Dawley rats[1]. parameter 32 PO Dose (mg/kg) 3 Tmax (h) 0.63(0.25-6) Cmax (µg/mL) 7.82±3.68 AUC0-t (µg.h/mL) 80.18±35.44 T1/2,po (h) 4.77±1.84 MRT (h) 7.54±2.52 IV Dose (mg/kg) 1 C0 (µg/mL) 4.70±2.50 AUC0-t (µg.h/mL) 18.89±1.76 Vss (L/kg) 0.32±0.14 CL (mL/min/kg) 0.85±0.13 T1/2,iv (h) 5.16±3.83 MRT (h) 6.69±4.03 %F 100Wistar rats; 3 mg/kg; p.o. (1% Tween 80 + 99% (0.5%) methyl cellulose in water); 1 mg/kg; i.v. (5% NMP + 5% solutol + 90% normal saline)[1] Animal Model: 7-10 weeks, 250-300g, male wistar rats[1] Dosage: Administration: 3 mg/kg for p.o.; 1 mg/kg for i.v. Result: Showed fast oral absorption, higher plasma exposure, extended oral half-life and excellent oral bioavailability of 100%. Animal Model: Female Sprague Dawley rats ( PGPS rat model)[1] Dosage: 10 mg/kg Administration: P.o.; once a day; 3 days Result: Showed anti-inflammatory effect.
References	[1]. Desai J, et al. Optimisation of momelotinib with improved potency and efficacy as pan-JAK inhibitor. Bioorg Med Chem Lett. 2022; 66:128728.

Molecular Formula	C₂₈H₃₀FN₇O₂
Molecular Weight	515.58

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.